QUOIN PHARMACEUTICALS
Quoin Pharmaceuticals is into developing products which address major unmet medical needs including the opioid epidemic and the military veteran suicide rate and chronic rare skin diseases such as Netherton syndrome and Dystrophic Epidermolysis Bullosa (DEB).
QUOIN PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2016-12-01
Address:
Ashburn, Virginia, United States
Country:
United States
Website Url:
http://www.quoinpharma.com
Status:
Active
Contact:
972 58-448-8821
Email Addresses:
[email protected]
Total Funding:
193.54 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Aclipse Therapeutics
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-04 | Quoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial Officer |
Official Site Inspections
http://www.quoinpharma.com Semrush global rank: 2 M Semrush visits lastest month: 10.63 K
- Host name: 156.31.68.34.bc.googleusercontent.com
- IP address: 34.68.31.156
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Quoin Pharmaceuticals"
Company | Quoin Pharmaceuticals
Formerly, he was President at Boulder Cove and Executive VP of Corporate and Product Development at Medicis Pharmaceutical. He also served as the Chief Business Officer of โฆSee details»
Corporate Governance - Quoin Pharmaceuticals, Inc.
The Board of Directors of Quoin Pharmaceuticals Ltd. (โQuoinโ) sets high standards for Quoin's employees, officers and directors. Implicit in this philosophy is the importance of sound โฆSee details»
Company Overview | Quoin Pharmaceuticals, Inc.
The Investor Relations website contains information about Quoin Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Quoin Pharmaceuticals - Crunchbase Company Profile โฆ
Contact Email [email protected] Phone Number 972 58-448-8821 Quoin Pharmaceuticals is into developing products which address major unmet โฆSee details»
Joseph Cooper | Quoin Pharmaceuticals
Jan 23, 2025 Mr. Cooper has served as a director of Quoin Inc. since May 2021. With 30 years of pharmaceutical industry experience, Mr. Cooper has held roles in operational, corporate โฆSee details»
Quoin Pharmaceuticals, Ltd. - Prism MarketView
Web: https://quoinpharma.com; About Quoin Pharmaceuticals, Ltd. Founded in 2018, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and โฆSee details»
News Release - investors.quoinpharma.com
Mar 6, 2025 [email protected]. Investor Relations PCG Advisory Jeff Ramson [email protected] (646) 863-6341. Subscribe. Sign up for alerts to stay up to date on โฆSee details»
Quoin Pharmaceuticals - Craft
Oct 29, 2024 Quoin Pharmaceuticals (formerly known as Cellect Biotechnology) is a pharmaceutical company that specializes in drug development solutions. It focuses on โฆSee details»
Quoin Pharmaceuticals Company Overview, Contact Details
Mar 5, 2024 To learn more about Quoin Pharmaceuticals please visit our website: www.quoinpharma.com. Sign up for free to view info. Email Format Employee directory . โฆSee details»
Quoin Pharmaceuticals Ltd. (Quoin Pharmaceuticals Ltd.) - ่ฏ็ฉ็ฎก โฆ
For more information, visit: www.quoinpharma.com or LinkedIn for updates. Cautionary Note Regarding Forward Looking Statements The Company cautions that statements in this press โฆSee details»
Pipeline - Quoin Pharmaceuticals
NORD National Organization for Rare Disorders. NORD is leading the fight to improve the lives of patients with rare diseases. Phone: 202-588-5700. Website: https://rarediseases.org. Genetic โฆSee details»
Quoin Pharmaceuticals - Overview, News & Similar companies
May 9, 2024 Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering - Yahoo Finance ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals โฆSee details»
Quoin Pharmaceuticals Provides Corporate Update and โฆ
For more information, visit: www.quoinpharma.com or LinkedIn for updates. Cautionary Note Regarding Forward Looking Statements. The Company cautions that statements in this press โฆSee details»
Quoin Pharmaceuticals Files U.S. Patent Application for Novel โฆ
1 day ago Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic DermatitisThird Quoin Patent Application for โฆSee details»
Contact - Quoin Pharmaceuticals
Corporate Office. 42127 Pleasant Forest Court Ashburn , VA, 20148-7349 (703) 980-4182 . Quoin Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to supporting โฆSee details»
Quoin Pharmaceuticals Files U.S. Patent Application for
1 day ago [email protected]. Investor Relations PCG Advisory Jeff Ramson [email protected] (646) 863-6341 ...See details»
PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr.
Jan 7, 2025 For more information, go to: www.quoinpharma.com. About PRISM MarketView Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small โฆSee details»
Quoin Pharmaceuticals Files Patent Application for QRX003 to โฆ
1 day ago [email protected]. Investor Relations PCG Advisory Jeff Ramson [email protected] (646) 863-6341. This article was originally published on Quiver โฆSee details»
Michael Sember | Quoin Pharmaceuticals
Mar 6, 2025 Mr. Sember has served as a director of Quoin Inc. since May 2021 and as a director of Quoin Ltd. since October 28, 2021. In his 40-year career, Mr. Sember has been COO or โฆSee details»
News Release - investors.quoinpharma.com
[email protected]. Investor Relations PCG Advisory Jeff Ramson [email protected] (646) 863-6341. Subscribe. Sign up for alerts to stay up to date on โฆSee details»